Skip Navigation


Carcinogenesis Advance Access originally published online on May 5, 2008
Carcinogenesis 2008 29(6):1139-1147; doi:10.1093/carcin/bgn103
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
29/6/1139    most recent
bgn103v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lei, P.
Right arrow Articles by Safe, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lei, P.
Right arrow Articles by Safe, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase

Ping Lei1, Maen Abdelrahim2,3, Sung Dae Cho1,4, Shengxi Liu1, Sudhakar Chintharlapalli1 and Stephen Safe1,5,*

1 Institute of Biosciences and Technology, Texas A&M University Health Science Center, Houston, TX 77030-3303, USA
2 Cancer Research Institute, M.D. Anderson Cancer Center—Orlando, Orlando, FL 32806, USA
3 Burnett College of Biomedical Sciences, University of Central Florida, Orlando, FL 32816, USA
4 Department of Oral Biology, School of Dentistry, Institute of Oral Biosciences, Chonbuk National University, Jeonju, Republic of Korea 561-756
5 Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77843-4466, USA

* To whom correspondence should be addressed. Tel: +1 979 845 5988; Fax: +1 979 862 4929; Email: ssafe{at}cvm.tamu.edu

1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes (C-DIMs) activate the orphan receptors peroxisome proliferator-activated receptor {gamma} (PPAR{gamma}) and Nur77 and induce receptor-dependent and -independent apoptotic pathways in colon and other cancer cells. Structure-activity studies show that the p-bromo (DIM-C-pPhBr) and p-fluoro (DIM-C-pPhF) analogs, which exhibit minimal activation of Nur77 and PPAR{gamma}, induce expression of CCAAT/enhancer-binding protein homologous protein (CHOP/GADD153) in colon cancer cells. Moreover, among a series of bromo and fluoro C-DIM analogs, their induction of CHOP was dependent on the position of the phenyl substituents (para ≥ meta ≥ ortho) and required a free indole group. DIM-C-pPhBr and DIM-C-pPhF not only induced CHOP but also activated death receptor 5 (CHOP dependent), cleavage of caspase 8 and poly (ADP ribose) polymerase (PARP) that is consistent with activation of the extrinsic pathway of apoptosis. These responses were associated with the activation of c-jun N-terminal kinase (JNK) pathway since inhibition of JNK inhibited induction of the extrinsic apoptotic pathway by these C-DIMs. However, in contrast to classical inducers of endoplasmic reticulum (ER) stress such as tunicamycin and thapsigargin, the C-DIM compounds did not induce glucose-related protein 78 that is a marker of ER stress. Proapoptotic and anticarcinogenic effects were also observed in athymic nude mice bearing RKO cell xenografts and treated with 30 mg/kg/day DIM-C-pPhBr and this was accompanied by increased JNK phosphorylation in the tumors. Thus, the anticarcinogenic activity of DIM-C-pPhBr in colon cancer cells and tumors is related to a novel ER stress-independent activation of JNK.

Abbreviations: ASK1, apoptosis signal-regulating kinase-1; C-DIM, 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methane; DIM, diindolylmethane; DMSO, dimethyl sulfoxide; DR5, death receptor 5; ER, endoplasmic reticulum; GRP78, glucose-related protein 78; JNK, c-jun N-terminal kinase; PARP, poly (ADP-ribose) polymerase; PBS, phosphate-buffered saline; PPAR{gamma}, peroxisome proliferator-activated receptor {gamma}; Tg, Thapsigargin; Tm, Tunicamycin

Received January 24, 2008; revised April 22, 2008; accepted April 24, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.